![Steven Almo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven Almo
Director/Board Member at New York Structural Biology Center, Inc.
Profile
Steven C.
Almo is the founder of Cue Biopharma, Inc. which was founded in 2014.
Currently, he is the Director at New York Structural Biology Center, Inc. and the Director at Institute For Protein Innovation, Inc.
Steven Almo active positions
Companies | Position | Start |
---|---|---|
New York Structural Biology Center, Inc.
![]() New York Structural Biology Center, Inc. BiotechnologyHealth Technology New York Structural Biology Center, Inc. provides resources in structural biology to its members and outside users. Its services include advanced instrumentation and expertise for NMR, X-ray crystallography and electron microscopy. The company was founded in 1999 and is headquartered in New York, NY. | Director/Board Member | - |
Institute For Protein Innovation, Inc.
![]() Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022. | Director/Board Member | - |
Former positions of Steven Almo
Companies | Position | End |
---|---|---|
CUE BIOPHARMA, INC. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CUE BIOPHARMA, INC. | Health Technology |
Private companies | 2 |
---|---|
New York Structural Biology Center, Inc.
![]() New York Structural Biology Center, Inc. BiotechnologyHealth Technology New York Structural Biology Center, Inc. provides resources in structural biology to its members and outside users. Its services include advanced instrumentation and expertise for NMR, X-ray crystallography and electron microscopy. The company was founded in 1999 and is headquartered in New York, NY. | Health Technology |
Institute For Protein Innovation, Inc.
![]() Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022. | Commercial Services |
- Stock Market
- Insiders
- Steven Almo